Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation
Neema P. Mayor(Anthony Nolan), Steven G. E. Marsh(CRUK Lung Cancer Centre of Excellence), Cynthia Vierra‐Green(National Marrow Donor Program), Yoshihiro Inamoto, Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Dominic J. Barker(Anthony Nolan), Loren Gragert(Tulane University), Vijaya Raj Bhatt(Susan Thompson Buffett Foundation), Sophie Paczesny(MUSC Hollings Cancer Center), Michelle Kuxhausen(National Marrow Donor Program), Peter J. Shaw(Children's Hospital at Westmead), Stephen R. Spellman(National Marrow Donor Program), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Ran Reshef(Abramson Cancer Center), Jeffery J. Auletta(Nationwide Children's Hospital), Olle Ringdén(Karolinska Institutet), Tao Wang(Medical College of Wisconsin), Gerald P. Morris(University of California San Diego)
Cited by 43
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655